Humulin 70/30 Biphasic Insulin Injection 10mL

• Biphasic human insulin (30% soluble insulin + 70% isophane insulin) suspension • Intermediate-acting premixed insulin for type 1 and type 2 diabetes • Provides both rapid post-meal control and basal coverage • 100 IU/mL concentration • 10 mL multi-dose vial (approximately 1000 IU total)

Humulin 70/30 Injection is a premixed human insulin suspension containing 30% short-acting (regular/soluble) insulin for rapid onset after meals and 70% intermediate-acting (isophane/NPH) insulin for longer basal coverage. The cloudy suspension requires gentle resuspension before each use to ensure uniform mixing. Indicated for adults, adolescents, and children with diabetes requiring twice-daily insulin therapy. Provides onset within 30 minutes, peak effect at 2–12 hours, and duration up to 24 hours. Suitable for subcutaneous injection using insulin syringes or compatible pens (with cartridges in some markets). Benefits • Convenient premixed ratio – no need to mix insulins manually • Mimics physiological insulin profile: rapid post-meal control + steady basal coverage • Suitable for twice-daily regimens (morning and evening) • Proven efficacy and safety profile of human insulin • Cost-effective compared to analogue premixes • Flexible dosing adjustments for individual needs How to Use • Resuspend gently by rolling vial between palms 10 times and inverting 10 times until uniformLy cloudy (do not shake vigorously) • Adults: usual starting dose 0.5–1 IU/kg/day divided into 2 injections (morning and evening) • Inject subcutaneously (abdomen, thigh, upper arm, or buttock) 15–30 minutes before meals • Rotate injection sites to prevent lipodystrophy • Use U-100 insulin syringes (marked in units) – draw exact prescribed dose • Unopened vials: refrigerate (2–8°C); do not freeze • In-use vial: store below 30°C for up to 28–42 days (check label) • Discard if suspension remains clear or has clumps after resuspension